PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

PLD

107.1

+1.84%↑

DLR

172.24

-0.26%↓

CCI

105

-2%↓

CSGP

96.51

-0.26%↓

WY

25.8

+2.14%↑

Search

Realty Income Corp

Închisă

SectorImobiliare

57.25 -0.35

Rezumat

Modificarea prețului

24h

Curent

Minim

57.16

Maxim

57.56

Indicatori cheie

By Trading Economics

Venit

50M

251M

Vânzări

40M

1.4B

P/E

Medie Sector

51.691

43.654

Randament dividend

5.46

Marjă de profit

18.215

Angajați

468

EBITDA

311M

1.1B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+7.83% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.46%

6.00%

Următoarele câștiguri

6 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

3.8B

51B

Deschiderea anterioară

57.6

Închiderea anterioară

57.25

Sentimentul știrilor

By Acuity

23%

77%

27 / 189 Clasament în Real estate

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Realty Income Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 aug. 2025, 21:42 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 aug. 2025, 21:21 UTC

Câștiguri
Principalele dinamici ale pieței

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 aug. 2025, 20:45 UTC

Câștiguri

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 aug. 2025, 19:15 UTC

Principalele dinamici ale pieței

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 aug. 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 aug. 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4 aug. 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4 aug. 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 aug. 2025, 21:30 UTC

Câștiguri

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 aug. 2025, 21:21 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 aug. 2025, 21:18 UTC

Câștiguri

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 aug. 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4 aug. 2025, 20:25 UTC

Câștiguri

Transocean 2Q Loss $938M >RIG

4 aug. 2025, 20:25 UTC

Câștiguri

Transocean 2Q Loss/Shr $1.06 >RIG

4 aug. 2025, 20:18 UTC

Câștiguri

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 aug. 2025, 20:15 UTC

Câștiguri

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 aug. 2025, 20:14 UTC

Câștiguri

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 aug. 2025, 20:14 UTC

Câștiguri

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 aug. 2025, 20:14 UTC

Câștiguri

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 aug. 2025, 20:13 UTC

Câștiguri

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 aug. 2025, 20:09 UTC

Câștiguri

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 aug. 2025, 20:06 UTC

Câștiguri

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 aug. 2025, 20:01 UTC

Câștiguri

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 aug. 2025, 20:01 UTC

Câștiguri

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 aug. 2025, 20:01 UTC

Câștiguri

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 aug. 2025, 20:01 UTC

Câștiguri

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 aug. 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 aug. 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 aug. 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 aug. 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparație

Modificare preț

Realty Income Corp Așteptări

Obiectiv de preț

By TipRanks

7.83% sus

Prognoză pe 12 luni

Medie 61 USD  7.83%

Maxim 68 USD

Minim 58 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruRealty Income Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

12 ratings

3

Cumpărare

9

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 56.89Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

27 / 189 Clasament în Imobiliare

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Realty Income Corp

Realty Income (NYSE: O), an S&P 500 company, is real estate partner to the world's leading companies. Founded in 1969, we invest in diversified commercial real estate and have a portfolio of 15,450 properties in all 50 U.S. states, the U.K., and six other countries in Europe. We are known as The Monthly Dividend Company and have a mission to deliver stockholders dependable monthly dividends that grow over time. Since our founding, we have declared 649 consecutive monthly dividends and are a member of the S&P 500 Dividend Aristocrats index for having increased our dividend for the last 29 consecutive years.